Weifa^[1] is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø.

Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.

Weifa was founded by pharmacist Olaf Weider in 1940.^[2]

Weifa focuses on three therapeutic areas:

1. Pain management
2. Diabetes management
3. Food supplements

• bra!: Evening primrose oil.
• Bronkyl: Expectorant effervescent tablet.^[3]
• Dexyl: Nasal spray.^[4]
• Fanalgin: Pain reliever and fever reducer with an addition of caffeine.^[5]
• Ferromax: Iron supplement.^[6]
• Fluormax: Fluorine supplements.^[7]
• Ibux: A brand name for ibuprofen.
• Ibux Gel: A gel version of Ibux.^[8]
• Nazamér: Salt water spray.^[9]
• Nazaren: Salt water nasal spray.^[10]
• Paracet: A brand name for paracetamol.^[11]
• Paracetduo: Similar to Paracet with the addition of caffeine for increased pain relief.^[12]
• Proxan: Brand name for naproxen.^[13]
• Pyrivir: Relieves symptoms of cold sores.^[14]
• Samin: Symptom relief in patients with Osteoarthritis.
• Tigerbalsam: Heat rub.^[15]
• Tussin: Cough medicine.^[16]
• Weifa-C Nypeekstrakt: Vitamin C from rose hip extract.
• Weifa C-vitamin brusetabletter: Vitamin C effervescent tablets.
• Weifa Kalsium: Calcium supplements.

• Codeine: Used in pain relievers and cough medicine.^[17]
• Metformin: Used in first-line treatment of diabetes mellitus type 2.^[18]
• Pholcodine: Used in cough medicine.^[17]

With a total of over 99 employees, Weifa is today generating an annual turnover of approximately €40 million (35% of the turnover is achieved internationally). Weifa bases its development on 3 criteria:

1. International expansion
2. Expertise in pharmaceuticals and fine chemicals
3. Partnership agreements

Weifa has market leadership in pain management products for the Norwegian market, with a portfolio of branded products that includes established brand names such as the Ibux tablets, Paracet tablets and Paralgin Forte tablets. Branded products accounts for approximately 70% of net sales.

Weifa’s leading export markets are Germany and United Kingdom. Besides these two essential export markets, Weifa has a long-standing presence in all the main countries of the European Union, in Eastern Europe, in Africa, in North America, in South America and in Asia.